Latest News about KZIA

Recent news which mentions KZIA

< Previous 1 2 3 4 Next >

Stocks That Hit 52-Week Lows On Thursday

October 27, 2022

Kazia Therapeutics Reveals Paxalisib Preclinical Data In Melanoma Animal Models

October 27, 2022

12 Health Care Stocks Moving In Thursday's Pre-Market Session

October 27, 2022

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

September 14, 2022

12 Health Care Stocks Moving In Tuesday's After-Market Session

September 06, 2022

Stocks That Hit 52-Week Lows On Wednesday

August 10, 2022

Biotech Daily: Thumbs Down For Acadia's Antipsychotic Drug, Akebia Fails COVID-19 Study, Kazia's Encouraging Data In Brain Metastases

August 05, 2022

Kazia Therapeutics Shares Jump On Interim Data From Paxalisib Combo Study In Brain Metastases

August 05, 2022

12 Health Care Stocks Moving In Friday's Pre-Market Session

August 05, 2022

Benzinga's Top Ratings Upgrades, Downgrades For August 2, 2022

August 02, 2022

Why Revlon Shares Jumped 90%; Here Are 83 Biggest Movers From Yesterday

August 02, 2022

U.S. Stocks Turn Negative; Dow Drops Over 100 Points

August 01, 2022

Stocks That Hit 52-Week Lows On Monday

August 01, 2022

12 Health Care Stocks Moving In Monday's Intraday Session

August 01, 2022

This Biotechnology Stock Is Trading Lower By 77%, Here Are 62 Stocks Moving In Monday's Mid-Day Session

August 01, 2022

U.S. Stocks Turn Higher; Crude Oil Tumbles

August 01, 2022

Why Stocks Are Trading Slightly Lower; U.S. Manufacturing PMI Slips

August 01, 2022

Daily Biotech Pulse: Celyad Resumes Colorectal Cancer Trial, Setback For Otonomy, AstraZeneca Halts Phase 3 Head, Neck Cancer Trial

August 01, 2022

12 Health Care Stocks Moving In Monday's Pre-Market Session

August 01, 2022

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

August 01, 2022

Kazia Shares Tumble After Update From Pivotal Brain Tumor Trial

August 01, 2022

Why Celyad Oncology Is Trading Higher By Over 31%; Here Are 29 Stocks Moving Premarket

August 01, 2022

Stocks That Hit 52-Week Lows On Thursday

July 28, 2022

12 Health Care Stocks Moving In Friday's After-Market Session

July 08, 2022

Kazia Therapeutics (KZIA) Stock Soars on FDA Designation

July 06, 2022

The Daily Biotech Pulse: FDA Decision On Biogen Alzheimer's Drug Due In January, FDA Reviews Roche's Lymphoma Candidate, Rare Pediatric Tag For Kazia's Pediatric Brain Cancer Candidate

July 06, 2022

Kazia Shares Shoot Higher As FDA Grants Rare Pediatric Disease Designation To Brain Cancer Candidate

July 06, 2022

Stocks That Hit 52-Week Lows On Friday

July 01, 2022

The Daily Biotech Pulse: Addex Terminates Parkinson's Study, Expanded Use Of Rhythm's Obesity Drug, FDA Approval For AbbVie's Skyrizi In Crohn's Disease

June 17, 2022

Kazia Therapeutics' Shares Gain Following FDA Orphan Drug Status For Childhood Brain Cancer Drug

June 17, 2022

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.